全球糖尿病:快速变化的格局与不断涌现的机遇——2025年糖尿病事业杰出国际服务奖演讲
文章指出可借鉴疫苗和抗逆转录病毒治疗全球合作经验,并强调糖尿病异质性、治疗技术增长和经济增长三大转型机遇,同时指出约80%疾病负担在中低收入国家而>95%研究在高收入国家的不平等问题。
要点
- 高收入国家并发症和死亡率下降,中低收入国家反而上升。
- 约80%疾病负担在中低收入国家,但>95%研究在高收入国家。
核心结论
- 全球糖尿病负担沉重且分布不均,中低收入国家负担增长迅速但研究证据严重不足,需战略性地弥合负担-知识差距。
研究设计与样本
- 本文为2025年糖尿病事业杰出国际服务奖演讲,基于全球证据综述与经验总结。
主要发现
- 高收入国家糖尿病相关并发症和死亡率下降,中低收入国家上升。
- 约80%糖尿病负担在中低收入国家,而>95%糖尿病相关研究在高收入国家人群中进行。
关键数值与推荐
- 约80%糖尿病负担在中低收入国家,>95%糖尿病相关研究在高收入国家。
临床怎么用
- 可借鉴疫苗和抗逆转录病毒治疗的全球合作经验,利用团队、任务转移、数据系统和决策支持工具。
- 关注糖尿病异质性及中低收入国家亚型频率差异。
- 利用移动健康、远程医疗和人工智能等技术克服基础设施限制。
- 利用中低收入国家经济增长投资健康和データ基础设施及研发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diabetes affects an estimated 828 million people worldwide; prevalence is growing rapidly in low- and middle-income countries (LMICs), with major health and development consequences. Diabetes-related complications and mortality rates have declined across several high-income countries (HICs), largely through structured chronic disease care, sustained implementation of quality improvement strategies, and active risk factor control. However, rates of diabetes complications and mortality have been rising in LMICs. Along with evidence there are tools (e.g., teams, task shifting, data systems, decision-support mechanisms, etc.) for translating the gains in HICs to LMICs. Lessons from global collaborations in vaccines and antiretroviral therapy, especially in innovative ways of leveraging infrastructure, and lowering costs of therapeutics, can be applied to diabetes prevention and control. Furthermore, the following are several transformational opportunities that, if leveraged, can propel global diabetes prevention and control: 1) increasing recognition of diabetes heterogeneity and the differences in the frequency of diabetes subtypes in LMICs; 2) growth in therapeutics and technologies (e.g., mobile health [mHealth], telemedicine, artificial intelligence), which can help overcome infrastructural constraints and stimulate innovative models of prevention care; and 3) sustained economic growth across several LMICs, which offers possibilities of investment in health and data infrastructure and in research and development. Importantly, while ∼80% of the diabetes burden is in LMICs, >95% of diabetes-related research occurs in populations residing in HICs. This burden-knowledge gap is a major source of health inequity that must be strategically addressed to effectively prevent and control diabetes globally.
引用
- Narayan KMV. Global Diabetes: Rapidly Changing Landscape and a Rising Tide of Opportunities: The 2025 Distinguished International Service in the Cause of Diabetes Award Lecture. Diabetes Care. 2026. PMID: 42475533. doi:10.2337/dci25-0116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。